ログイン
Language:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学会発表・講演等
  2. ポスター発表

Radiolabeling of DBCO-containing DOTA derivative using copper-64 and zirconium-89

https://repo.qst.go.jp/records/2002047
https://repo.qst.go.jp/records/2002047
92abe918-ca91-477c-96f8-ffe4caa4ea63
アイテムタイプ 会議発表用資料 / Presentation(1)
公開日 2025-04-21
タイトル
タイトル Radiolabeling of DBCO-containing DOTA derivative using copper-64 and zirconium-89
言語 en
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6670
資源タイプ conference poster
著者 Hanyu Masayuki

× Hanyu Masayuki

Hanyu Masayuki

Search repository
Kadoma Ayumi

× Kadoma Ayumi

Kadoma Ayumi

Search repository
Suzuki Hisashi

× Suzuki Hisashi

Suzuki Hisashi

Search repository
Xie Lin

× Xie Lin

Xie Lin

Search repository
Zhang Ming-Rong

× Zhang Ming-Rong

Zhang Ming-Rong

Search repository
抄録
内容記述 Objective: The chelator is introduced by reacting an active ester or acid anhydride with the ε-amino group of the Lys residue in the antibody. However, because these reactions are random, it is not known which Lys residue in the antibody has been introduced with a chelator. In addition, the number of chelating agents introduced into the antibody varies from preparation to preparation. In other words, if it is possible to prepare antibodies in which the introduction of a chelator is site-specific and the number of introductions is clear, it is believed that the above problem can be improved. In the field of radiopharmaceutical chemistry, click chemistry is used in a variety of applications, including bioconjugation, radiolabeling, probe purification, and in vivo pre-targeting [1]. Thus, by performing a click reaction between an azide group and a DBCO group, it is possible to combine different radionuclides, i.e. to introduce radionuclides for diagnosis or treatment using a common chelating structure. Various methods have been reported for the introduction of site-specific azide groups into amino acid residues in antibodies, and the synthesis is relatively straightforward. We report the radiolabeling of the DBCO-containing DOTA derivative group using copper-64 and zirconium-89.Method: The copper-64 and zirconium-89 radioactivity were produced using a remotely controlled versatile system developed in our house [2, 3]. The conversion of 89Zr(Ox)x to 89ZrCl4 was carried out with reference to the literature [4]. Results: The labeling reaction was performed at room temperature for 10 min with DOTA-DBCO/DMSO (50 μL, 2 mg/mL) and 64CuCl2 (300 μL, acetate buffer, 0.1 mol/L, pH 5.0). The radiochemical yield of 64Cu-DOTA-DBCO was very low (<5%). There was no improvement in yield even when the labeling reaction was performed at 70°C. When the solubility of DBCO-DOTA was investigated using various buffer solutions, it was found that DBCO-DOTA at a concentration of 10 mg/mL could be prepared using acetate buffer (3 mol/L, pH 5.2). Accordingly, a labeling reaction was conducted at 70 °C for 10 minutes using DBCO-DOTA/acetate buffer (30 μL, 10 mg/mL, 3 moL/L, pH 5.2) and 64CuCl2 (300 μL, acetate buffer, 0.1 mol/L, pH 5.0). The radiochemical yield of 64Cu-DOTA-DBCO was greatly improved (>98%). It was found that the yield of the labeling reaction between DBCO-DOTA and copper-64 was significantly affected by the organic solvent. Next, we used the above labeling reaction conditions in a reaction with 89ZrCl4, but the yield was low (<20%). We are currently investigating conditions to improve the yield. We also report on the radiolabeling of DOTA derivatives that can be used as substrates for click reactions.Summary: We successfully radiosynthesized 64Cu-DOTA-DBCO for application in click reaction for the radiolabeling of antibodies.Reference: [1] Bauer, D., et al, Bioconjugate Chem., 2023, 34, 1925-1950. [2] Ohya, T., et al. Nucl. Med. Biol., 2016, 43, 685-691. [3] Nagatsu, K., et al Nucl. Med. Biol., 2012, 39, 1281-1285. [4] Holland J. P., et al Nucl. Med. Biol., 2009, 36, 729-739.Acknowledgements: This work was supported by AMED under Grant Number 21zf0127003h001.
会議概要(会議名, 開催地, 会期, 主催者等)
内容記述 iSRS2025
発表年月日
日付 2025-05-12
戻る
0
views
See details
Views

Versions

Ver.1 2026-01-15 06:06:38.766691
Show All versions

Share

Share
tweet

Cite as

Other

print

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX
  • ZIP

コミュニティ

確認

確認

確認


Powered by WEKO3


Powered by WEKO3